Skip to main content
. 2020 Oct 8;11:581277. doi: 10.3389/fphar.2020.581277

Table 4.

Comparison of the adverse events between the groups with or without QFDYG.

Adverse events ST (n = 35) ST+QFDYG (n = 49) P
Total 19 (54.29%) 23 (46.94%) 0.507
Nausea 8 (22.86%) 11(22.45) 0.965
Abnormal liver function 5 (14.29%) 4(8.16%) 0.371
Vomiting 1 (2.86%) 1 (2.04) 0.809
Headache 3 (8.57%) 4 (8.16) 0.947
Abnormal renal function 2 (5.71%) 3 (6.12%) 0.938